๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model

โœ Scribed by P. Ramani; F. R. Balkwill


Publisher
John Wiley and Sons
Year
1989
Tongue
French
Weight
675 KB
Volume
43
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


The therapeutic potential of rHulFN-a A/D, a hybrid human IFN molecule with equal activity on murine cells, was studied in experimental and spontaneous metastatic models of a murine colon carcinoma COLON 26. rHulFN-a! A/D inhibited experimental pulmonary metastases of COLON 26 and prolonged the survival of BALB/c mice. Dose scheduling, survival and tumour-cell clearance studies showed that the first 5 days were critical in the inhibition of pulmonary metastases. However, it is unlikely that lung N K cells were involved in the anti-metastatic effect of rHulFN-a AID because inhibition of pulmonary metastases and a decrease in radio-labelled tumour-cell survival was seen in BALBlc mice depleted selectively of their NK cells by prior treatment with rabbit anti-asialoGM, serum. Although rHuIFN-a A/D stimulated NK-cell activity in BALB/c mice, it was ineffective in abrogating the NK suppressant action of rabbit anti-asialoGMl serum on murine lung NK cells. Thus, IFN may mediate its early antimetastatic effect via a mechanism independent of NK-cell stimulation. IFN also inhibited the development of lung metastases from S.C. COLON 26 tumours in normal, NK-depleted and T-cell-deficient mice.


๐Ÿ“œ SIMILAR VOLUMES


Inhibition of experimentally-induced mur
โœ Michael J. Brunda; Deborah Rosenbaum; Lorraine Stern ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 600 KB

The effect of a human recombinant hybrid alpha interferon (referred to as rHulFN-alphaA/D) on pulmonary metastases induced by intravenous injection of B16 FIO melanoma cells in C57BU6 mice was examined; rHulFN-alphaAID has been previously shown to have anti-viral, anti-proliferative and immunomodula

In vivo anti-tumor activity of combinati
โœ Michael J. Brunda; Donna Bellantoni; Viveca Sulich ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 684 KB

The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met

Anti-tumor effect of recombinant murine
โœ M. Scheringa; A. Keizer; J. Jeekel; R. L. Marquet ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 508 KB

Anti-tumor effects of TNF in animal models are well documented. Therapeutic use of TNF, however, is hampered by its toxicity. In rats a single intravenous (i.v.) injection of 40 pg/kg is lethal. When given by continuous i.v. infusion, much higher doses are well tolerated. To compare the therapeutic